You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide expert, targeted care and compassionate support throughout your treatment and beyond.
We guide you every step of the way, combining our deep clinical expertise in chronic lymphocytic leukemia (CLL) with a commitment to meet your unique needs.
Why choose SCCA for CLL treatment?
Leukemia survival rates
Leukemia patients who begin treatment at SCCA have better survival rates on average than those who started treatment elsewhere.
Comprehensive CLL treatment
Our doctors are experts in the complex factors that go into planning your individualized CLL treatment. Based on the specific features of your disease, your team may recommend one or more targeted therapies or immunotherapies — or in some cases chemotherapy or bone marrow transplant — all available at SCCA.
CLL clinical studies
To give you access to the most innovative therapies, SCCA unites the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in CLL clinical studies not available everywhere.
Pioneering new approaches
In recent years, CLL treatment has changed significantly, with the approval of several targeted drugs and antibody therapies that have largely replaced conventional chemo. Researchers here helped pioneered novel options, and we continue to refine treatment combinations and sequences to get the best results for each patient.
A national leader in cancer treatment
SCCA is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report.
NCI comprehensive cancer center
We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer.
Request an appointment
Call (855) 557-0555 to request an appointment, refer a patient or learn more about CLL care at SCCA.